Retatrutide is in Phase 3 clinical trials through Eli Lilly, and cagrilintide is in Phase 3 trials through Novo Nordisk (both as monotherapy and as part of CagriSema)
In the Pioneer 1 study, participants took daily oral semaglutide at doses of 3 mg, 7 mg, or 14 mg, or a placebo
The Super Bowl reaches a large, national audience that reflects the challenges facing the U.S
The push for sustainability and clean-label products has spurred manufacturers to innovate in these segments
Whether you're an athlete aiming to improve your performance, or simply an individual yearning to gain some lean muscle mass, you'd know that muscle building is not always the easiest journey
Weight loss response can vary because factors such as hormone status, muscle mass, sleep quality, activity level, and metabolic health all influence how the body responds to a medication dose